These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1973362)

  • 21. Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.
    Kury FD; Schneeberger C; Sliutz G; Kubista E; Salzer H; Medl M; Leodolter S; Swoboda H; Zeillinger R; Spona J
    Oncogene; 1990 Sep; 5(9):1403-8. PubMed ID: 1699198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
    Schneider PM; Hung MC; Chiocca SM; Manning J; Zhao XY; Fang K; Roth JA
    Cancer Res; 1989 Sep; 49(18):4968-71. PubMed ID: 2569928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
    Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ
    Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
    Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
    Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes.
    Lichtenstein A; Berenson J; Gera JF; Waldburger K; Martinez-Maza O; Berek JS
    Cancer Res; 1990 Nov; 50(22):7364-70. PubMed ID: 1977519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers.
    Freeman MR; Washecka R; Chung LW
    Cancer Res; 1989 Nov; 49(22):6221-5. PubMed ID: 2572319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.
    Liu C; Tsao MS
    Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.
    Hollstein MC; Smits AM; Galiana C; Yamasaki H; Bos JL; Mandard A; Partensky C; Montesano R
    Cancer Res; 1988 Sep; 48(18):5119-23. PubMed ID: 3044581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HER-2/neu oncogene expression and proliferation in breast cancers.
    Bacus SS; Ruby SG; Weinberg DS; Chin D; Ortiz R; Bacus JW
    Am J Pathol; 1990 Jul; 137(1):103-11. PubMed ID: 1973597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
    Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
    Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells.
    Koskinen P; Lehväslaiho H; MacDonald-Bravo H; Alitalo K; Bravo R
    Oncogene; 1990 Apr; 5(4):615-8. PubMed ID: 1970155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell line.
    Köhler G; Veelken H; Rosenthal F; Mackensen A; Lindemann A; Schaefer HE; Lahn M
    Anticancer Res; 1997; 17(5A):3225-31. PubMed ID: 9413152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCR V beta 3+ and V beta 6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancers.
    Peoples GE; Yoshino I; Douville CC; Andrews JV; Goedegebuure PS; Eberlein TJ
    J Immunol; 1994 May; 152(10):4993-9. PubMed ID: 7909829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.